test

Raymond Debbane

@Siren, L.l.c.

Latest period2024 - Q3ReportedManaged Assets$2BTotal holdings110
Assets growth rate0%Assets growth rate (2-Q avg)0%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Siren, L.l.c.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 110 positions.

Assets under management

The assets under management (AUM) of Siren, L.l.c. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2B in assets, with a quarterly growth rate of 0% and a 2-quarter average growth rate of 0%. The portfolio is managed by Raymond Debbane, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
EWTXEdgewise Therapeutics Inc
Recent Activity
New Position
0.54%
$10.786M
404,113 shares@ $26.7 avg price
IOVAIovance Biotherapeutics Inc
Recent Activity
New Position
0.52%
$10.386M
1.106M shares@ $9.4 avg price
ORICOric Pharmaceuticals Inc
Recent Activity
New Position
0.52%
$10.328M
1.008M shares@ $10.26 avg price
IONSIonis Pharmaceuticals Inc
Recent Activity
New Position
0.51%
$10.015M
250,000 shares@ $40.06 avg price
TSHATaysha Gene Therapies Inc
Recent Activity
New Position
0.5%
$9.809M
4.88M shares@ $2.02 avg price
MSFTMicrosoft Corp
Recent Activity
New Position
0.48%
$9.463M
22,000 shares@ $430.12 avg price
RNACCartesian Therapeutics Inc
Recent Activity
New Position
0.47%
$9.224M
572,236 shares@ $16.12 avg price
SLRNAcelyrin Inc
Recent Activity
New Position
0.43%
$8.527M
1.73M shares@ $4.93 avg price
PHATPhathom Pharmaceuticals Inc
Recent Activity
New Position
0.42%
$8.33M
460,753 shares@ $18.08 avg price
SEERSeer Inc
Recent Activity
New Position
0.4%
$7.88M
4M shares@ $1.97 avg price